Schonfeld Strategic Advisors LLC
Position in RCUS — Arcus Biosciences, Inc.
CIK 1665241
NEW YORK, NY
Position in RCUS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,180,917
+$1,862,664 QoQ
Shares Held
193,561
+99.0% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Schonfeld Strategic Advisors LLC holds $296,187,490 across 126 Biotechnology names. RCUS ranks #22 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,757,899 | $25,419,219 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
71,767 | $23,745,547 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
318,405 | $21,692,932 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
324,722 | $18,882,584 | |
| 5 | INBX |
Inhibrx Biosciences, Inc.
|
254,827 | $17,132,019 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
62,142 | $11,747,945 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
494,737 | $10,364,740 | |
| 8 | INSM |
INSMED Inc
|
56,056 | $9,166,277 |
All Filings in RCUS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,180,917 | 193,561 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,318,253 | 97,283 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $664,958 | 48,894 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $438,973 | 53,928 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,071,430 | 136,488 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,010,105 | 134,997 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,302,983 | 673,838 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,545,452 | 232,794 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,960,876 | 103,860 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,408,662 | 230,820 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,565,055 | 142,900 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,717,217 | 183,024 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,359,094 | 293,810 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,191,730 | 154,339 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,417,228 | 130,628 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,195,999 | 165,588 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $1,007,703 | 24,900 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $850,828 | 24,400 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $1,423,684 | 50,701 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $405,625 | 15,625 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||